IRB Protection of Human Subjects - The University of Tulsa

IRB Protection of Human Subjects

Recent TU Research Community Notices

For more details about the changes that went into effect on January 21, 2019, please see 2018 Common Rules and Regulations.

Conducting Research with Human Subjects during the COVID-19 Pandemic

Notices on COVID-19 and Human Subjects Research

Forms and Guidance on COVID-19 and Conducting Human Subjects Research

TU Institutional Review Board (IRB) Plan:

General Plan from the Office of Research and Sponsored Programs:

The use of human participants in research is extremely important to the development of new knowledge in many areas. However, careful attention must be given to the questions of ethics and human dignity whenever human subjects participate in research. 

It is the policy of The University of Tulsa to require that all research activities by faculty, staff and students involving human participants follow the procedures and guidelines established by the Institutional Review Board (IRB) at The University of Tulsa as well as those established by the Department of Health and Human Services Office of Human Research Protections (OHRP). Regardless of the nature or degree of risk anticipated, the applicant must present in writing, and be prepared to defend in person before the IRB, detailed information on the following points:

  1. The possible risks to the rights and welfare of human subjects, including the rights of privacy, freedom from undue harassment, and confidentiality of data; a description of the provisions made to minimize these risks must be provided.
  2. Methods used to acquire informed consent, with special emphasis on their appropriateness to the particular situation inherent in the study plan.
  3. The relative risks and benefits of the project.

The Institutional Review Board is composed of faculty, staff and lay members (both scholars and non-scholars) who are trained in the importance of academic freedom, the protection of the rights and welfare of human research participants, federal regulations about research ethics, and the ethical regulations of various funding agencies.

Student, faculty and staff are encouraged to contact the Coordinator of Research Compliance to receive help with the Human Subjects research issues and the IRB components of their research.

Upcoming TU IRB Meeting Dates

    • Friday, September 17,  2021, 2:00PM
    • Friday, October 22, 2021, 2:00PM
    • Friday, November 19, 2021, 2:00PM
    • Friday, December 17, 2021, 2:00PM

Although the TU IRB posts the meeting dates for each current semester, meeting dates/times are subject to change. If you would like to confirm a meeting date/time, please contact, 918-631-3310.

Mandatory IRB Training

TU IRB Policies and Procedures

TU IRB General Application Forms

TU IRB Guidance and Reference Materials

TU IRB Informed Consent Form Options

TU IRB Payments to Human Subjects Forms

TU Student Course-Related Research Guidelines

Classroom projects that meet ALL the criteria for “Student Course-Related Research Projects”, need not undergo review by the IRB; however, instructors and students are encouraged to follow federal and university regulations when designing and conducting class projects with human participants.

To determine if a project is a “Student Course-Related Research Project” please see The University of Tulsa IRB policy:

If in doubt or for additional information, please contact the or 918-631-3310 for consultation.

Other Reference Links

Office of Human Subjects Protections FAQs

Clinical Trials Information

Definition of a clinical trial: a research study designed to test the safety and/or effectiveness of drugs, devices, treatments, or preventive measures in humans

Who is required to register on clinical Registration is required by law, Section 113 of the FDA Modernization Act mandates registration with of investigational new drug efficacy trials for serious diseases or conditions and is also required by The International Committee of Medical Journal Editors (ICMJE) as a condition for publication of research results generated by a clinical trial. Other journals may follow these guidelines as well. The National Institutes of Health (NIH) is committed to providing information to increase public awareness and access to clinical trials sponsored federally and by industry foundations.

Contact:, 918-631-3310